Finally, while the downstream regulatory pathways of NUSAP1 have been extensively studied in various types of tumors, the specific regulatory mechanisms of NUSAP1 in promoting the progression of HBV-HCC require further exploration and verification through additional clinical samples. This evidence concerns the gene NUSAP1 and hepatocellular carcinoma.